Barbituric acid is converted into a pyrimidinone-incorporated pyrazolyl moiety (1), which is a key starting material. 1 can be converted into pyrimidine dione, isoxazole, pyrimidopyrimidine, and pyranopyrimidine by reacting with hydrazine hydrate and/or phenyl hydrazine, hydroxyl amine, urea, thiourea, guanidine, ethyl acetoacetate and ethyl cyanoacetate. Acylation of 1 gave an important key intermediate (7), which was condensed to form chalcone, which then underwent cycloaddition into cyclohexenes (8-13). Some newly synthesized compounds were screened as anti-diabetic agents and exhibited significant activity. These freshly prepared compounds were characterized using different methods. These compounds showed significant activity as anti-diabetic agents, especially compound 4b, with IC 50 = 13.54 μg/ml, which is very close to that of the standard acarbose (IC 50 = 12.87 μg/ ml). Additionally, these compounds showed cytotoxic inhibition activity against the colon carcinoma (HCT116), hepatocellular carcinoma (HEPG2), and breast carcinoma (MCF7) cells; compounds 11, 4b, and 10 showed the best activity, with IC50= 19.3, 2.6, and 5 μg/ml, respectively.
INTRODUCTION
Barbituric acid is a heterocyclic compound derived from pyrimidine. Pyrimidinones constitute a very important class of six-membered heterocyclic compounds that are widely distributed because of their importance as anti-HIV agents 1 and antimicrobial agents 2, 3 .
Barbituric acid, one of the most important naturally occurring heterocyclic compounds, serves as the fundamental compound in barbiturate drugs and is involved in a wide variety of biological activities like-Urease Inhibitors 4 adipogenesis of 3T3-L1, 5 antidiabetic and antibacterial agents 6 PPARγ activators 7 protease inhibitors 8 potential antimicrobial 9 an anesthetic drugs 10 . This high activity may be due to the reactive chemical structure (pyrimidine trione). Barbituric acid is a parent compound of drugs called barbiturates.
Barbiturates have attracted considerable focus among researchers due to its involvement in different biological activities like-antioxidant 11 antibacterial agents 12 . As a continuation of our previous work 13 , we hope to convert barbituric acid into new heterocyclic compounds, with a focus on the application of these compounds by way of being an effective precursor in the process of preparing various new molecules of heterocyclic bio-active compounds bearing bioactive pyrazolyl 14 isoxazoles 15 pyranoes, cyclohexene 16 moieties for the purpose of increasing the biological reactivity capability in the molecules. Now, the newly manufactured compounds get screened for use as anti-diabetic and anti-cancer agents.
FTIR spectra showed bands at 1625 cm - 
3-(5-chloro-4-methyl-1-phenyl-1H-pyrazol-3-yl)-2H-pyrazolo[3,4 d]pyrimidine-4,6(5H,7H)-dione (2a), 3-(5-chloro-4-methyl-1-phenyl-1H-pyrazol-3-yl)-2-phenyl-2H-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione (2b)
Reflux (0.02 mol) of 1, hydrazine hydrate (0.02 mol) in ethanol (30 ml) for 6 hours. Once the solution cooled down, filtration was performed of the separated solid, washed clean using water, dried down to remove moisture, and recrystallized using EtOH. Yield 84% and the melting point (m.p.) 201-203°C.Yield of 2b 65% and the melting point (m.p.) 273-274°C.Elemental Analysis of 2a C 15 
3-(5-chloro-4-methyl-1-phenyl-1H-pyrazol-3-yl) isoxazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione (3)
Reflux (0.012 mol) of 1 and (0.012
MATERIAL AND METHODS
All commercial reagents; barbituric acid, ethyl acetoacetate, ethyl cyanoacetate, and hydrazine hydrate were obtained from SigmaAldrich. These regents were then put to use without using a purifying process. Melting temperature of the regents was then measured through use of an electro-thermal digital apparatus without making any correction. Recording of KBr (IR spectra) was done by use of the system Perkin Elmer Spectrum RXIFT-IR. Measurement of 1 HNMR, 13 C-NMR was done through use of Varian Gemini 850 MHZ instrument alongside TMS.
5-((5-chloro-4-methyl-1-phenyl-1H-pyrazol-3-yl) methylene)pyrimidine-2,4,6(1H,3H,5H)-trione (1)
Barbituric acid (0.01 mol) was introduced stirred to the mixture of sodium ethoxide (0.5 g in 10 milliliter solution of ethanol) and pyrazolone (0.01mol) at 27 o C. Afterwards the whole solution was mixed for 60 min at the temperature of 100 degreeCelsius. Once the solution cooled down, filtration was performed of the separated solid, washed clean using water, dried down to remove moisture, and recrystallized using EtOH.
Yield is 74% and melting point (mp) 187-188°C. In (20 ml) glacial acetic acid reflux (0.012 mol) of 1, combined with guandine, thiourea, and urea HCl for 5 hours. Once the solution cooled down, filtration was performed of the separated solid, washed clean using water, dried down to remove moisture, and recrystallized using EtOH. Yield 74% and melting point (mp) 214-215°C. Analysis of 4a C 16 
6-acetyl-5-(5-chloro-4-methyl-1-phenyl-1H-pyrazol-3-yl)-7-hydroxy-6,7 dihydro-1H-pyrano [2,3-d]pyrimidine-2,4(3H,8aH)-dione (5)
Reflux in In (20 ml) ethanol, reflux (0.012 mol) of 1 and (0.012 mol) of ethyl cyanoacetate for the duration of 5 hours. Once the solution cooled down, filtration was performed of the separated solid, washed clean using water, dried down to remove moisture, and recrystallized using EtOH. 
1-acetylpyrimidine-2,4,6(1H,3H,5H)-trione (7)
Stirring (0.012 mol) of compound 1, (0.012 mol) acetyl chloride in a water container for 3 h and then pouring the whole solution in ice results in compound 7. Once the solution cooled down, filtration was performed of the separated solid, washed clean using water, dried down to remove moisture, and recrystallized using EtOH. 
1-(3-(5-chloro-4-methyl-1-phenyl-1H-pyrazol-3-yl) acryloyl)pyrimidine-2,4,6(1H,3H,5H)-trione (8)
Stir in ice bath pyrazolone ethanolic solution (0.12 mol) and (0.04 mol) of 7 and then adding 5 ml of NAOH in a 10% aqueous concentration in a drop-system for 30 minutes. Once the solution cooled down, filtration was performed of the separated solid, washed clean using water, dried down to remove moisture, and recrystallized using EtOH. 
6-ethyl 6-(5-chloro-4-methyl-1-phenyl-1H-pyrazol-3-yl)-2-oxo-4-(2,4,6-trioxotetrahydropyrimidin-1(2H)-yl)cyclohex-3-enecarboxylate (9)
Reflux (0.01 mol) of compound 8 in 20 milliliter of ethanol, 0.5 sodium metal in ten milliliter of ethanol (sodium ethoxide) and ethyl acetoacetate for six hours. Afterwards, the solution is kept overnight to cool down and upon recrystallization, the ethanol is separated from the solid content. Yield of 9 is 82% and melting point (mp) 255-256°C. 5-chloro-4-methyl-1-phenyl-1H-pyrazol-3-yl)-3-oxo-4-(5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl) cyclohex-1-en-1-yl)pyrimidine-2,4,6  (1H,3H,5H) , 3330, 3340 cm 1 for √ C=N, √ C=O, √ NH 2 respectively. The ion peak was determined using a mass spectrum and it was m/z 509(M + , 5-chloro-4-methyl-1-phenyl-1H-pyrazol-3-yl)-4-(8,8a-dihydro-[1,2,4]triazolo[5,1-c][1,2, 
1-(5-(

4] triazin-7-yl)-3-oxocyclohex-1-en-1-yl)pyrimidine-2,4,6(1H,3H,5H)-trione (12)
Dissolve (0.012 mol) of 11 in xylene (20 ml), add formic acid (0.012 mol) then reflux the mixture for six hours. Once the solution is cooled down, filtration was performed of the separated solid, washed clean using water, dried down to remove moisture, and recrystallized using EtOH. 
1,1'-(4,4'-(5,5'-(2,2'-methylenebis(hydrazine-2,1-diyl))bis(4H-1,2,4-triazole-5,3-diyl))bis(5-(5-chloro-4-methyl-1-phenyl-1H-pyrazol-3-yl)-3-oxocyclohex-1-ene-4,1-diyl))dipyrimidine-2,4,6 (1H,3H,5H)-trione (13)
Reflux for three hours (0.012 mol) formaldehyde and (0.012 mol) of compound 11, 3 ml of HCl. Once the solution cools down, filtration was performed of the separated solid, washed clean using water, dried down to remove moisture, and recrystallized from ethanol. Yield of 13 Cl) (1.02%).
1-(4-(7H-[1,2,4]triazolo[1,5-d]tetrazol-6-yl)-5-(5-chloro-4-methyl-1-phenyl-1H-pyrazol-3-yl)-3-oxocyclohex-1-en-1-yl)pyrimidine-2,4,6(1H, 3H,5H)-trione (14)
Stir (0.012 mol) of 11, sodium nitrite (0.012 mol), acetic acid (3.5 ml) in ethanol (25 ml) at 27 o C for 4 hours. Once the solution cooled down, filtration was performed of the separated solid, washed clean using water, dried down to remove moisture, and recrystallized from ethanol. 
Biological Assessment Anti-diabetic Evaluation
Five new compounds, 1, 4b, 8, 12, and 14, were evaluated for their effect as inhibitors of NIDDM compared to the standard acarbose. α-Amylase and acarbose were used by the Anti-Diabetic Activity Division in RCMB (Regional Center for Mycology and Biotechnology). For the purpose of detecting the inhibitory activity, the derivative solution was tested in different concentrations (3.9, 7.8, 15.6, 31.25, 62.5, 125, 250, and 500 μg/mL). IC 50 value is the value representation of the concentration of the new derivative which is needed to keep 50% inhibiting of α-amylase activity. The revelation from the outcomes is that the IC 50 of the control was 12.87 μg and that compounds 4b, 12, and 14 showed IC 50 values of 13.54, 17.08, and 21.359 μg/ml, respectively. The high potency of these compounds can be explained by the structure-activity relationship, where the reactivity of compound 4b is attributed to the presence of a thione group. Thus, the derivatives bearing a strong electronwithdrawing group showed potent activity. Likewise, the reactivity of compounds 12 and 14 is attributed to the triazine moiety fused with tetrazoles. 
Anti-cancer Evaluation
The anti-tumor cytotoxicity of compounds 1, 2a, 4b, 5, 6, 9, 10, 11, and 14 was assessed and compared to that of doxorubicin as a reference; a total of 3 types of cancer cell lines were tested, namely: HCT116, HEPG2, and MCF7. IC 50 values and cytotoxicity values of each solution were tested as shown in (Table 2-4) . With an increase in the concentration of the sample compound, a gradual decrement was detected in the survival fraction. As shown in the results table, in the samples 10, 6, 4a, and 11, the compounds scored the lowest values for IC 50 , which is a signifier that these compounds serve as the highest potent cytotoxic drugs. The high potency of these compounds can be explained by the structure-activity relationship, where the reactivity of compound 4b is attributed to the presence of a thione group that takes advantage of the electronwithdrawing group substituted on the pyrimidine ring, that of compound 6 is credited to involvement of an element belonging to a carbonitrile group, and that of compounds 10 and 11 is attributed to the presence of a cyclohexene moiety. On the other hand, the 1,3-dipolar cyclocondensation of 1 with different carbamides, namely, urea, thiourea and guanidine HCl, in glacial acetic acid afforded derivatives 4a, b, and c. The formation of the six-membered pyrimidine ring was confirmed by the spectral data; for example, compound 4b resulted in the IR spectrum with a clear absorption band at 1410 cm -1 for νC=S. Additionally, the 
RESULT AND DISCUSSION
Synthesis and characterization
Condensation of barbituric acid via Knoevenagel condensation through the reactive methylene group within the 5-chloro-4-methyl-1-phenyl-1H-pyrazole-3-carbaldehyde moiety, which had been prepared by the conventional methods 17 afforded the corresponding α, β-unsaturated pyrazol-3-ylmethylenepyrimidine-2,4,6-trione, which leads to a new heterocyclic derivatives, as shown in Scheme 1. This new chalcone undergoes nucleophilic cycloaddition after treatment with hydrazine hydrate or phenyl hydrazine in boiling ethyl alcohol, causing production of 2a and b, as indicated by the absence of a signal at δ 6.52 ppm attributed to C=CH in the 1 H-NMR spectrum. Additionally, the 2(a-b), 3, 4(a-c), 5 and 6 On the other hand, condensation of chalcone with ethyl acetoacetate or ethyl cyanoacetate via the reactive methylene group followed by elimination of ethanol or water, respectively, and then cyclization to form compounds 5 and 6, respectively. H-NMR showed singlet bands at δ 5.03 and 4.24 ppm corresponding to CH-O and CHCN, respectively, which proved the formation of a six-membered ring.The acetylation of barbituric acid with acetyl chloride in a water bath afforded 7. This acetylation occurred on only the NH group, while the other group gave rise to a singlet signal in the 1 H-NMR spectrum at δ 10.22 ppm. This acetylated derivative is one of the initial materials use to synthesize the new compounds, as shown in Scheme 2. Condensation of 7 with pyrazole-3-carbaldehyde in ethanol and 10% sodium hydroxide yielded the pyrazol-3-yl(acryloyl)pyrimidine-2,4,6-trione derivative 8; although condensation was thought to occur at the methylene group of the pyrimidinone ring, an occurrence of a singlet band at δ 3.03 ppm in the 1 H-NMR spectrum and the absence of a singlet band for NHCOCH 3 indicated that the condensation occurred at the methyl group 18 .
The identity of compound 8 was chemically confirmed by treating 8 with the dicarbonyl compound ethyl acetoacetate in ethanol and sodium ethoxide to yield cyclohexanone-3-enecarboxylate 9, which is consistent with the data from the IR spectrum showing absorption bands at 1190 cm -1 for νC-O. On the 1 H-NMR spectrum, there was a quartet signal at δ 3.65 alongside a triplet band at 1.45 for COCH 2 CH 3 of the carboxylate group. The formation of the cyclohexenone group was also indicated by 1 H-NMR, which showed a quartet signal at δ 3.44 attributed to CHCHCH 2 and doublet signals at 3.28 and 3.22 ppm that correspond to CHCHCH 2 . The nucleophilic addition of thiosemicarbazide to 9 in presence of sodium ethoxide produced compound10, as confirmed by the spectral data showing an absorption band at 1410 cm -1 refer to νC=S. The reaction of 10 with hydrazine hydrate compound in boiling ethanol gave 11. On the IR spectrum, there was no reading of an absorption band forming, which can be explained through νC=S and stretching bands at 3330 and 3340 cm -1 attributable to νNH 2 . Additionally, the formation of the hydrazinyl group was indicated via 1 H-NMR, which showed a triplet signal at 4.89 ppm corresponding to NHNH 2 and a doublet at 2.55 ppm corresponding to NHNH 2 .
This new hydrazinyl derivative was chemically confirmed using a formic acid treatment in boiling ethanol to form sample compound 12. The reaction was carried out through formation of the hydrazinyl group followed by cyclization. The spectral data revealed the absence of NH 2 and the formation of the triazine ring. Treatment of 11 with formaldehyde in boiling HCl afforded dimer 12. This dimer was thought to be formed via condensation between 2 mol of the hydrazinyl derivative and formaldehyde. The expected structure agrees with spectral data, the ion peak of the solution was noted using a mass spectrum and it was m/z 1030 (M + , 35.5 Cl) (2.06%).
The hydrazinyl derivative converted into 14 via reaction with nitrous acid through diazotization of the hydrazinyl group. The formation of the tetrazole derivative is confirmed by spectral data. Data collected using spectral analysis and elemental analysis was used to prove the structured of all the newly synthesized compounds.
α-Amylase Assay
`In order to measure the inhibition efficiency of the compounds in α-amylase, the protocol defined by McCue 19 was used with some minor changes to fit the experiment adequately. For the purpose of determining the α-amylase inhibitory activity, each compound was tested using different concentration samples in methanol. For the testing, each fraction was taken in 250 micro-liter in volume or varying concentrations (from 30 to 240 micro-liter/ml) of acarbose. This mixture was then subjected to incubation for twenty minutes at 37 degree-Celsius in a porcine pancreatic amylase (2 U/ml) in a buffer of phosphate (100 mM and pH value of 6.8). Afterwards, 250 micro-liter of 1% starch dissolved in the buffer of 100 mM phosphate (pH value of 6.8) is also added to the aforementioned mixture. The resulting solution is subjected to incubation for one hour at temperature of 37 degree-Celsius. This mixture is then boiled for a duration of ten minutes after adding a color reagent in the form of Dinitrosalicylate. For the final mixture compound, the value of absorbance is noted at 540 nm. In this procedure of α-amylase, the standard benchmark was Acarbose. To describe the inhibitory potential of the compound in α-amylase, a percentage value is represented that is calculated using the following formula:
Where A t = the absorbance of the compound tested A c = the absorbance of control.
Cytotoxic Activity
The new derivatives were tested against human cancer cell lines at the Anti-Tumor Activity Unit in the RCMB. Three different cancer cell lines, MCF7, HEPG2, and HCT116 were procured in a frozen state submerged inside liquid nitrogen from the American Type Culture Collection. Serial subculturing method was used to maintain the tumor cell lines. The potential cytotoxicity of 1, 2a, 4b, 5, 6, 9, 10, 11, and 14, as well as doxorubicin, was validated using the method described by Skehan et al., 20 . The relationship of the drug concentrations in μg/mL was plotted against the cell viability to obtain the survival fraction IC 50 values of the new derivatives.
Scheme 2. Synthesis of compounds 7-14
CONCLUSION
Conversion of barbituric acid into new heterocyclic compounds results in the formation of a new series of bioactive molecules containing the pyrimidine nucleus incorporated with pyrazolyl, pyrimidone, isoxazole, pyranone, and triazole moieties. Data collected using spectral analysis and elemental analysis was used to prove the structured of all the newly synthesized compounds. The anti-diabetic reactivity of some of the synthesized compounds was verified in vitro. Some compounds showed high inhibition activity, and compound 4b was the most active (IC 50 13.54 μg/ml), with an activity very close to that of the standard acarbose. The structureactivity relationship of these compounds was studied, and the reactivity of compound 4b is attributed to the presence of a thione group. Compound 4b (IC 50 2.6 μg/ml) has the potential use in the form of a cytotoxic drug for treatment of breast carcinoma cells. 11 (IC 50 19.3 μg/ml) can be used for liver carcinoma cells, and 6 and 10 (IC 50 7.7, 5 μg/ml) can be used as colon carcinoma cell cytotoxic drugs.
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